Table 2.
Ligand | IκK-NEMO | IκK | p65-Rel A | |||
---|---|---|---|---|---|---|
Lowest binding energy (kcal/mol) | pKi (μM) | Lowest binding energy (kcal/mol) | pKi (μM) | Lowest binding energy (kcal/mol) | pKi (nM) | |
Baicalin | −3.79 ± 0.50 | 1690 ± 155.56 | −5.97 ± 0.04 | 42.47 ± 2.43 | −9.68 ± 0.09 | 79.88 ± 11.99 |
β-hydroxy-DHP | −5.04 ± 0.05 | 203.52 ± 18.09 | −5.87 ± 0.18 | 52.24 ± 14.46 | −8.54 ± 0.04 | 553.70 ± 33.52 |
Isoliquiritin | −3.59 ± 0.17 | 2390.00 ± 692.97 | −7.04 ± 0.08 | 6.92 ± 0.98 | −9.97 ± 0.22 | 61.00 ± 4.24 |
Isoliquiritin apioside | −1.20 ± 0.12 | 132.78 ± 28.65 | −6.90 ± 0.15 | 9.00 ± 2.28 | −10.10 ± 0.74 | 56.59 ± 8.56 |
Liquiritin | −4.12 ± 0.28 | 1155.00 ± 247.49 | −6.10 ± 0.19 | 34.91 ± 11.08 | −9.20 ± 0.04 | 180.31 ± 14.99 |
Ononin | −3.82 ± 0.02 | 1600.00 ± 70.71 | −7.33 ± 0.01 | 4.24 ± 0.07 | −11.55 ± 0.08 | 3.43 ± 0.50 |
Oroxyloside | −3.32 ± 0.08 | 3690.00 ± 551.54 | −6.16 ± 0.04 | 30.84 ± 1.90 | −9.41 ± 0.02 | 127.50 ± 4.95 |
Fluoxetine (R) | −4.35 ± 0.05 | 652.97 ± 54.98 | −5.61 ± 0.06 | 77.65 ± 8.25 | −7.35 ± 0.07 | 4093.33 ± 475.01 |
Fluoxetine (S) | −4.14 ± 0.05 | 928.59 ± 79.41 | −5.90 ± 0.03 | 47.15 ± 2.48 | −7.63 ± 0.03 | 2543.33 ± 123.42 |
Albiflorin | −5.05 ± 0.30 | 211.37 ± 52.00 | −6.63 ± 0.16 | 14.23 ± 3.77 | −10.66 ± 0.50 | 23.85 ± 3.12 |
Paeonflorin | −4.41 ± 0.04 | 591.13 ± 29.66 | −7.83 ± 0.21 | 2.09 ± 0.27 | −11.25 ± 0.03 | 5.45 ± 0.07 |
Pentagalloyl-β-D-glucose | −0.67 ± 0.01 | 320580.00 ± 150.00 | −2.39 ± 0.49 | 19090.00 ± 3490.00 | −6.09 ± 0.21 | 35.50 ± 1.27 |
MG-132 | −3.50 ± 0.63 | 47053.00 ± 1090.00 | −7.75 ± 0.35 | 2.31 ± 0.33 | −9.07 ± 0.29 | 172.10 ± 27.01 |
IκK, IκB kinase; IκK, NEMO. NF-κB essential modulator; NF-κB, nuclear factor kappa; light, chain-enhancer of activated B cells.